Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Nov 6;81(4):e245-e246.
doi: 10.1093/cid/ciaf249.

A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection: The Failure of a Procedure, not of a Therapy

Nadim Cassir  1   2   3   4 , Nicolas Benech  1   2   5   6   7 , Tatiana Galperine  1   8 , Laurent Alric  1   9 , Julien Scanzi  1   10   11 , Alexandre Bleibtreu  1   12   13   14 , Nathalie Kapel  1   15   16 , Harry Sokol  1   14   17   18   19
Affiliations

A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection: The Failure of a Procedure, not of a Therapy

Nadim Cassir et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. N. C. received travel grants from Tillots Pharma. N. B. received lecture fees from Tillots Pharma and travel grants from Pfizer, participated on an advisory board for Ferring Pharmaceuticals with payment to his institution, and is a principal investigator of a clinical trial supported by Exeliom Biosciences. T. G. received travel grants from Tillots Pharma. L. A. received consultancy or lecture fees, travel grants from: Abbvie, Gilead, Janssen, BMS, MSD, Novartis, Almylan, Viatrix, and Takeda. J. S. received consultancy, or lecture fees, from Biocodex, Mayoly Spindler, Sanofi, Pileje, Janssen, Dynveo, Havea, Activia, and Bioderma, and travel grants from Sandoz and Biocodex. A. B. declares links of interest with Pfizer, Shionogi, Eumedica, Sanofi, Gilead, Astellas, Menarini, and Janssen for congress fees, symposia, or being investigator in clinical studies. N. K. received a grant from Maat for a collaborative research study. H. S. received consultancy, or lecture fees, from Biocodex, Abbvie, Astellas, Danone, Ferring, Mayoly Spindler, MSD, Novartis, Roche, Janssen, Tillots, Enterome, Maat, Ipsen, MSD, BiomX, Galapagos, Biose, Biogen, Novartis, Lilly, Viatris, Nestlé, Urgo, Adare, Fresenius, Celltrion, Sanofi, and Takeda, has stocks from Enterome, and is a cofounder of Exeliom Bioscience.

LinkOut - more resources